Testing effectiveness (Phase 2)Looking for participantsNCT06540937
What this trial is testing
Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Who this might be right for
Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50